Sugi Predict

Sugi Predict / Compounds / SCHEMBL29581042

SCHEMBL29581042

SCHEMBL29581042

CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](CO)OC(O)[C@@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.67
▸ MAG P20916 8/20 0.64
▸ SELL P14151 1/20 0.58
▸ SELP P16109 1/20 0.58
▸ SELE P16581 1/20 0.51
▸ CD22 P20273 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716446 0.99 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL30653356 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL29454528 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31716709 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717356 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31700918 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31716426 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31700333 0.97 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL31716746 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717084 0.96 MAG (0.67) SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025224348-A1 PRODUCTION OF A MILK OLIGOSACCHARIDE MIXTURE INBIOSE N.V. (BE) 2025-10-30 — — WO claimed
WO-2025224348-A1 PRODUCTION OF A MILK OLIGOSACCHARIDE MIXTURE INBIOSE N.V. (BE) 2025-10-30 — — WO disclosed
EP-4539679-A1 USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF BIFIDOBACTERIA DSM IP Assets B.V. (NL) 2025-04-23 — — EP disclosed
EP-4539678-A1 USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF LACTOBACILLI DSM IP Assets B.V. (NL) 2025-04-23 — — EP disclosed
WO-2023247577-A1 USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF LACTOBACILLI DSM IP ASSETS B.V. (NL) 2023-12-28 — — WO disclosed
WO-2023247578-A1 USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF BIFIDOBACTERIA DSM IP ASSETS B.V. (NL) 2023-12-28 — — WO disclosed
Send feedback